Company intelligence / Profile preview

Avails Medical

Menlo Park, California, United Statesavailsmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Avails Medical has developed the FDA-cleared eQUANT™ System, which enables rapid preparation of samples for direct-from-positive-blood-culture antimicrobial susceptibility testing (AST), reducing time to actionable results by up to 24 hours for common gram-negative bacteria. The company is also piloting its next-generation eAST™ system, designed for fully automated, electrical AST directly from positive blood cultures with same-day reporting potential. Early clinical data and pilot trials are ongoing; no large-scale published clinical outcomes yet.

Therapeutic areas: Infectious Diseases
Modalities: DeviceElectronic biosensor platform
Industry: Molecular Diagnostics

Partnerships

CARB-X (funding/investment partnership)StartX (accelerator/investor partnership)

Beyond the preview

Go deeper on Avails Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avails Medical.

Explore the full profile